Although the CAD with the Asp1371 mutation did not enhance the binding to previously reported interacting proteins, nor did it increase the de novo synthesis of pyrimidine nucleotides, whether the mutated form of CAD exhibits any other functions in cancer cells remains unknown to us. The gene discussed is CAD; the disease is cancer.